
TY  - JOUR
TI  - Abstract Presentations from the AABB Annual Meeting Philadelphia, PA, October 25-28, 2014
JO  - Transfusion
JA  - Transfusion
VL  - 54
IS  - S2
SN  - 0041-1132
UR  - https://doi.org/10.1111/trf.12845
DO  - doi:10.1111/trf.12845
SP  - 15A
EP  - 268A
PY  - 2014
ER  - 

TY  - JOUR
TI  - POSTERS
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 19
IS  - s2
SN  - 0926-9959
UR  - https://doi.org/10.1111/j.1468-3083.2005.01311.x
DO  - doi:10.1111/j.1468-3083.2005.01311.x
SP  - 1
EP  - 411
PY  - 2005
ER  - 

C7  - pp. 892-932
TI  - Index
SN  - 9781405199407
UR  - https://doi.org/10.1002/9781118689943.index
DO  - doi:10.1002/9781118689943.index
SP  - 892-932
KW  - No keyword
PY  - 2005
ER  - 

TY  - JOUR
AU  - Celentano, Antonio
AU  - Mignogna, Michele Davide
AU  - McCullough, Michael
AU  - Cirillo, Nicola
TI  - Pathophysiology of the Desmo-Adhesome
JO  - Journal of Cellular Physiology
JA  - J. Cell. Physiol.
VL  - 232
IS  - 3
SN  - 9781405199407
UR  - https://doi.org/10.1002/jcp.25515
DO  - doi:10.1002/jcp.25515
SP  - 496
EP  - 505
PY  - 2017
AB  - Advances in our understanding of desmosomal diseases have provided a clear demonstration of the key role played by desmosomes in tissue and organ physiology, highlighting the importance of their dynamic and finely regulated structure. In this context, non-desmosomal regulatory molecules have acquired increasing relevance in the study of this organelle resulting in extending the desmosomal interactome, named the ?desmo-adhesome.? Spatiotemporal changes in the expression and regulation of the desmo-adhesome underlie a number of genetic, infectious, autoimmune, and malignant conditions. The aim of the present article was to examine the structural and functional relationship of the desmosome, by providing a comprehensive, yet focused overview of the constituents targeted in human disease. The inclusion of the novel regulatory network in the desmo-adhesome pathophysiology opens new avenues to a deeper understanding of desmosomal diseases, potentially unveiling pathogenic mechanisms waiting to be explored. J. Cell. Physiol. 232: 496?505, 2017. ? 2016 Wiley Periodicals, Inc.
ER  - 

TY  - JOUR
TI  - Abstracts presented at the 52nd Annual Meeting of the American Society of Dermatopathology
JO  - Journal of Cutaneous Pathology
JA  - J Cutan Pathol
VL  - 43
IS  - 1
SN  - 9781405199407
UR  - https://doi.org/10.1111/cup.12663
DO  - doi:10.1111/cup.12663
SP  - e1
EP  - e139
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstract Presentations from the AABB Annual Meeting Anaheim, CA, October 24–27, 2015
JO  - Transfusion
JA  - Transfusion
VL  - 55
IS  - S3
SN  - 9781405199407
UR  - https://doi.org/10.1111/trf.13294
DO  - doi:10.1111/trf.13294
SP  - 3A
EP  - 245A
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts Oral Presentations – Educational Day
JO  - Clinical & Experimental Immunology
VL  - 154
IS  - s1
SN  - 9781405199407
UR  - https://doi.org/10.1111/j.1365-2249.2008.03767.x
DO  - doi:10.1111/j.1365-2249.2008.03767.x
SP  - 1
EP  - 224
PY  - 2008
ER  - 

TY  - JOUR
TI  - Case Reports
JO  - Nephrology
JA  - Nephrology
VL  - 19
IS  - S4
SN  - 9781405199407
UR  - https://doi.org/10.1111/nep.12303
DO  - doi:10.1111/nep.12303
SP  - 89
EP  - 97
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts of the papers presented at the 43rd Annual Meeting of The American Society of Dermatopathology
JO  - Journal of Cutaneous Pathology
VL  - 34
IS  - 1
SN  - 9781405199407
UR  - https://doi.org/10.1111/j.1600-0560.2006.00691.x
DO  - doi:10.1111/j.1600-0560.2006.00691.x
SP  - 79
EP  - 138
PY  - 2007
ER  - 

TY  - JOUR
AU  - Garzon, Maria C.
AU  - Kahn, Teri A.
AU  - Siegfried, Elaine C.
AU  - Silverman, Robert A.
AU  - Paller, Amy S.
TI  - Proceedings of the Society for Pediatric Dermatology Meeting, June 29—July 1, 1995, Vancouver, British Columbia, Canada
JO  - Pediatric Dermatology
VL  - 12
IS  - 4
SN  - 9781405199407
UR  - https://doi.org/10.1111/j.1525-1470.1995.tb00207.x
DO  - doi:10.1111/j.1525-1470.1995.tb00207.x
SP  - 376
EP  - 385
PY  - 1995
ER  - 

TY  - JOUR
TI  - British Society for Dermatopathology: Summaries of Papers
JO  - British Journal of Dermatology
VL  - 153
IS  - s1
SN  - 9781405199407
UR  - https://doi.org/10.1111/j.1365-2133.2005.06653.x
DO  - doi:10.1111/j.1365-2133.2005.06653.x
SP  - 64
EP  - 73
PY  - 2005
ER  - 

TY  - JOUR
TI  - Administrative Operations
JO  - Transfusion
VL  - 47
IS  - s3
SN  - 9781405199407
UR  - https://doi.org/10.1111/j.1537-2995.2007.01507_2.x
DO  - doi:10.1111/j.1537-2995.2007.01507_2.x
SP  - 217A
EP  - 279A
PY  - 2007
ER  - 

TY  - JOUR
TI  - Scientific
JO  - Transfusion
VL  - 47
IS  - s3
SN  - 9781405199407
UR  - https://doi.org/10.1111/j.1537-2995.2007.01507_1.x
DO  - doi:10.1111/j.1537-2995.2007.01507_1.x
SP  - 1A
EP  - 216A
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Session
JO  - Nephrology
JA  - Nephrology
VL  - 19
IS  - S2
SN  - 9781405199407
UR  - https://doi.org/10.1111/nep.12237
DO  - doi:10.1111/nep.12237
SP  - 77
EP  - 202
PY  - 2014
ER  - 

TY  - JOUR
AU  - Padmanabhan, Anand
AU  - Connelly-Smith, Laura
AU  - Aqui, Nicole
AU  - Balogun, Rasheed A.
AU  - Klingel, Reinhard
AU  - Meyer, Erin
AU  - Pham, Huy P.
AU  - Schneiderman, Jennifer
AU  - Witt, Volker
AU  - Wu, Yanyun
AU  - Zantek, Nicole D.
AU  - Dunbar, Nancy M.
AU  - Schwartz, Guest Editor: Joseph
TI  - Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
JO  - Journal of Clinical Apheresis
JA  - J Clin Apher
VL  - 34
IS  - 3
SN  - 9781405199407
UR  - https://doi.org/10.1002/jca.21705
DO  - doi:10.1002/jca.21705
SP  - 171
EP  - 354
PY  - 2019
AB  - ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis (TA) in human disease. Since the 2007 JCA Special Issue (Fourth Edition), the committee has incorporated systematic review and evidence-based approaches in the grading and categorization of apheresis indications. This Eighth Edition of the JCA Special Issue continues to maintain this methodology and rigor in order to make recommendations on the use of apheresis in a wide variety of diseases/conditions. The JCA Eighth Edition, like its predecessor, continues to apply the category and grading system definitions in fact sheets. The general layout and concept of a fact sheet that was introduced in the Fourth Edition, has largely been maintained in this edition. Each fact sheet succinctly summarizes the evidence for the use of TA in a specific disease entity or medical condition. The Eighth Edition comprises 84 fact sheets for relevant diseases and medical conditions, with 157 graded and categorized indications and/or TA modalities. The Eighth Edition of the JCA Special Issue seeks to continue to serve as a key resource that guides the utilization of TA in the treatment of human disease.
ER  - 

TY  - JOUR
TI  - Poster Abstract
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 47
IS  - S1
SN  - 9781405199407
UR  - https://doi.org/10.1111/eci.12749
DO  - doi:10.1111/eci.12749
SP  - 87
EP  - 178
PY  - 2017
ER  - 

TY  - JOUR
AU  - Tomescu, C.
AU  - Abdulhaqq, S.
AU  - Montaner, L. J.
TI  - Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN)
JO  - Clinical & Experimental Immunology
VL  - 164
IS  - 2
SN  - 9781405199407
UR  - https://doi.org/10.1111/j.1365-2249.2011.04379.x
DO  - doi:10.1111/j.1365-2249.2011.04379.x
SP  - 158
EP  - 169
KW  - dendritic cells
KW  - HIV-1 exposed seronegative
KW  - intravenous drug-user
KW  - natural killer cells
PY  - 2011
AB  - Summary The description of highly exposed individuals who remain seronegative (HESN) despite repeated exposure to human immunodeficiency virus (HIV)-1 has heightened interest in identifying potential mechanisms of HIV-1 resistance. HIV-specific humoral and T cell-mediated responses have been identified routinely in HESN subjects, although it remains unknown if these responses are a definitive cause of protection or merely a marker for exposure. Approximately half of HESN lack any detectible HIV-specific adaptive immune responses, suggesting that other mechanisms of protection from HIV-1 infection also probably exist. In support of the innate immune response as a mechanism of resistance, increased natural killer (NK) cell activity has been correlated with protection from infection in several high-risk cohorts of HESN subjects, including intravenous drug users, HIV-1 discordant couples and perinatally exposed infants. Inheritance of protective NK KIR3DL1high and KIR3DS1 receptor alleles have also been observed to be over-represented in a high-risk cohort of HESN intravenous drug users and HESN partners of HIV-1-infected subjects. Other intrinsic mechanisms of innate immune protection correlated with resistance in HESN subjects include heightened dendritic cell responses and increased secretion of anti-viral factors such as ?-chemokines, small anti-viral factors and defensins. This review will highlight the most current evidence in HESN subjects supporting the role of epithelial microenvironment and the innate immune system in sustaining resistance against HIV-1 infection. We will argue that as a front-line defence the innate immune response determines the threshold of infectivity that HIV-1 must overcome to establish a productive infection.
ER  - 

TY  - JOUR
TI  - Poster Session
JO  - The Journal of Dermatology
VL  - 39
IS  - s1
SN  - 9781405199407
UR  - https://doi.org/10.1111/j.1346-8138.2012.01624.x
DO  - doi:10.1111/j.1346-8138.2012.01624.x
SP  - 53
EP  - 280
PY  - 2012
ER  - 

AU  - Kogan, Avi N
AU  - von Andrian, Ulrich H
C7  - pp. 449-482
TI  - Lymphocyte Trafficking
UR  - https://doi.org/10.1002/cphy.cp020410
DO  - doi:10.1002/cphy.cp020410
SP  - 449-482
PY  - 2012
AB  - Abstract The sections in this article are:
ER  - 

TY  - JOUR
TI  - Abstracts cont.
JO  - Clinical Microbiology and Infection
VL  - 11
IS  - s2
UR  - https://doi.org/10.1111/j.1469-0691.2005.clm_1134_03.x
DO  - doi:10.1111/j.1469-0691.2005.clm_1134_03.x
SP  - 391
EP  - 545
PY  - 2005
ER  - 
